Cargando…

Co‐designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom

BACKGROUND: In older people living with frailty, polypharmacy can lead to preventable harm like adverse drug reactions and hospitalization. Deprescribing is a strategy to reduce problematic polypharmacy. All stakeholders should be actively involved in developing a person‐centred deprescribing proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silcock, Jonathan, Marques, Iuri, Olaniyan, Janice, Raynor, David K., Baxter, Helen, Gray, Nicky, Zaidi, Syed T. R., Peat, George, Fylan, Beth, Breen, Liz, Benn, Jonathan, Alldred, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854320/ https://www.ncbi.nlm.nih.gov/pubmed/36420768 http://dx.doi.org/10.1111/hex.13669

Ejemplares similares

Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study
por: Peat, George, et al.
Publicado: (2022)

Mapping the resilience performance of community pharmacy to maintain patient safety during the Covid-19 pandemic
por: Peat, George, et al.
Publicado: (2022)

Supporting medicines management for older people at care transitions – a theory-based analysis of a systematic review of 24 interventions
por: Tomlinson, Justine, et al.
Publicado: (2021)

Experiences of patients with heart failure with medicines at transition intervention: Findings from the process evaluation of the Improving the Safety and Continuity of Medicines management at Transitions of care (ISCOMAT) programme
por: Powell, Catherine, et al.
Publicado: (2022)

Experience‐based co‐design—Adapting the method for a researcher‐initiated study in a multi‐site setting
por: Raynor, David K., et al.
Publicado: (2020)

A rapid review of interventions to improve medicine self‐management for older people living at home
por: Previdoli, Giorgia, et al.
Publicado: (2023)

Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge
por: Fylan, Beth, et al.
Publicado: (2019)

A non-randomised feasibility study of an intervention to optimise medicines at transitions of care for patients with heart failure
por: Fylan, Beth, et al.
Publicado: (2021)

Patients as qualitative data analysts: Developing a method for a process evaluation of the ‘Improving the Safety and Continuity of Medicines management at care Transitions’ (ISCOMAT) cluster randomised control trial
por: Powell, Catherine, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot
por: Moreau, Lauren A, et al.
Publicado: (2022)

Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial
por: Powell, Catherine, et al.
Publicado: (2020)

Post‐discharge medicines management: the experiences, perceptions and roles of older people and their family carers
por: Tomlinson, Justine, et al.
Publicado: (2020)

Successful care transitions for older people: a systematic review and meta-analysis of the effects of interventions that support medication continuity
por: Tomlinson, Justine, et al.
Publicado: (2020)

Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - a randomized controlled trial
por: Knapp, Peter, et al.
Publicado: (2011)

Associations Between Anticholinergic Medication Exposure and Adverse Health Outcomes in Older People with Frailty: A Systematic Review and Meta-analysis
por: Mehdizadeh, David, et al.
Publicado: (2021)

Performance-based readability testing of participant information for a Phase 3 IVF trial
por: Knapp, Peter, et al.
Publicado: (2009)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

A systematic review of the evidence for deprescribing interventions among older people living with frailty
por: Ibrahim, Kinda, et al.
Publicado: (2021)

Developing a core outcome set for hospital deprescribing trials for older people under the care of a geriatrician
por: Martin-Kerry, Jacqueline, et al.
Publicado: (2022)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Ethnic differences in the prevalence of frailty in the United Kingdom assessed using the electronic Frailty Index
por: Pradhananga, Shraddha, et al.
Publicado: (2019)

Interrupting the trajectory of frailty in dementia with Lewy bodies with anabolic exercise, dietary intervention and deprescribing of hazardous medications
por: Inskip, Michael, et al.
Publicado: (2020)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Optimised patient information materials and recruitment to a study of behavioural activation in older adults: an embedded study within a trial
por: Knapp, Peter, et al.
Publicado: (2020)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
por: Springer, Sydney P., et al.
Publicado: (2022)

Can we improve recruitment to trials and informed consent by improving participant information sheets? - A nested RCT
por: Knapp, Peter, et al.
Publicado: (2011)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Intervention Design With Cognitively Impaired Populations: The Optimize Deprescribing Intervention
por: Sheehan, Orla, et al.
Publicado: (2021)

CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change intervention
por: Scott, Sion, et al.
Publicado: (2023)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Barriers and facilitators to deprescribing in primary care: a systematic review
por: Doherty, Alison Jayne, et al.
Publicado: (2020)

Making it work for me: beliefs about making a personal health record relevant and useable
por: Fylan, Fiona, et al.
Publicado: (2018)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3eppsm8lpdu25auecnkkiot3ru